Vena Cava, Superior
Vena Cava, Inferior
Vena Cava Filters
Superior Vena Cava Syndrome
The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation. (1/230)
1. Arachidonic acid (0.01-1 microM) induced relaxation of precontracted rings of rabbit saphenous vein, which was counteracted by contraction at concentrations higher than 1 microM. Concentrations higher than 1 microM were required to induce dose-dependent contraction of vena cava and thoracic aorta from the same animals. 2. Pretreatment with a TP receptor antagonist (GR32191B or SQ29548, 3 microM) potentiated the relaxant effect in the saphenous vein, revealed a vasorelaxant component in the vena cava response and did not affect the response of the aorta. 3. Removal of the endothelium from the venous rings, caused a 10 fold rightward shift in the concentration-relaxation curves to arachidonic acid. Whether or not the endothelium was present, the arachidonic acid-induced relaxations were prevented by indomethacin (10 microM) pretreatment. 4. In the saphenous vein, PGE2 was respectively a 50 and 100 fold more potent relaxant prostaglandin than PGI2 and PGD2. Pretreatment with the EP4 receptor antagonist, AH23848B, shifted the concentration-relaxation curves of this tissue to arachidonic acid in a dose-dependent manner. 5. In the presence of 1 microM arachidonic acid, venous rings produced 8-10 fold more PGE2 than did aorta whereas 6keto-PGF1alpha and TXB2 productions remained comparable. 6. Intact rings of saphenous vein relaxed in response to A23187. Pretreatment with L-NAME (100 microM) or indomethacin (10 microM) reduced this response by 50% whereas concomitant pretreatment totally suppressed it. After endothelium removal, the remaining relaxing response to A23187 was prevented by indomethacin but not affected by L-NAME. 7. We conclude that stimulation of the cyclo-oxygenase pathway by arachidonic acid induced endothelium-dependent, PGE2/EP4 mediated relaxation of the rabbit saphenous vein. This process might participate in the A23187-induced relaxation of the saphenous vein and account for a relaxing component in the response of the vena cava to arachidonic acid. It was not observed in thoracic aorta because of the lack of a vasodilatory receptor and/or the poorer ability of this tissue than veins to produce PGE2. (+info)Pulmonary and caval flow dynamics after total cavopulmonary connection. (2/230)
OBJECTIVE: To assess flow dynamics after total cavopulmonary connection (TCPC). DESIGN: Cross-sectional study. SETTING: Aarhus University Hospital. PATIENTS: Seven patients (mean age 9 (4-18) years) who had previously undergone a lateral tunnel TCPC mean 2 (0. 3-5) years earlier. INTERVENTIONS: Pressure recordings (cardiac catheterisation), flow volume, and temporal changes of flow in the lateral tunnel, superior vena cava, and right and left pulmonary arteries (magnetic resonance velocity mapping). RESULTS: Superior vena cava flow was similar to lateral tunnel flow (1.7 (0.6-1.9) v 1. 3 (0.9-2.4) l/min*m2) (NS), and right pulmonary artery flow was higher than left pulmonary artery flow (1.7 (0.6-4.3) v 1.1 (0.8-2. 5) l/min*m2, p < 0.05). The flow pulsatility index was highest in the lateral tunnel (2.0 (1.1-8.5)), lowest in the superior vena cava (0.8 (0.5-2.4)), and intermediate in the left and right pulmonary arteries (1.6 (0.9-2.0) and 1.2 (0.4-1.9), respectively). Flow and pressure waveforms were biphasic with maxima in atrial systole and late ventricular systole. CONCLUSIONS: Following a standard lateral tunnel TCPC, flow returning via the superior vena cava is not lower than flow returning via the inferior vena cava as otherwise seen in healthy subjects; flow distribution to the pulmonary arteries is optimal; and some pulsatility is preserved primarily in the lateral tunnel and the corresponding pulmonary artery. This study provides in vivo data for future in vitro and computer model studies. (+info)Rate-dependent conduction block of the crista terminalis in patients with typical atrial flutter: influence on evaluation of cavotricuspid isthmus conduction block. (3/230)
BACKGROUND: The crista terminalis (CT) has been identified as the posterior boundary of typical atrial flutter (AFL) in the lateral wall (LW) of the right atrium (RA). To study conduction properties across the CT, rapid pacing was performed at both sides of the CT after bidirectional conduction block was achieved in the cavotricuspid isthmus by radiofrequency catheter ablation. METHODS AND RESULTS: In 22 patients (aged 61+/-7 years) with AFL (cycle length, 234+/-23 ms), CT was identified during AFL by double electrograms recorded between the LW and posterior wall (PW). After the ablation procedure, decremental pacing trains were delivered from 600 ms to 2-to-1 local capture at the LW and PW or coronary sinus ostium (CSO). At least 5 bipolar electrograms were recorded along the CT from the high to the low atrium next to the inferior vena cava. No double electrograms were recorded during sinus rhythm in that area. Complete transversal conduction block all along the CT (detected by the appearance of double electrograms at all recording sites and craniocaudal activation sequence on the side opposite to the pacing site) was observed in all patients during pacing from the PW or CSO (cycle length, 334+/-136 ms), but it was fixed in only 4 patients. During pacing from the LW, complete block appeared at a shorter pacing cycle length (281+/-125 ms; P<0.01) and was fixed in 2 patients. In 3 patients, complete block was not achieved. CONCLUSIONS: These data suggest the presence of rate-dependent transversal conduction block at the crista terminalis in patients with typical AFL. Block is usually observed at longer pacing cycle lengths with PW pacing than with LW pacing. This difference may be a critical determinant of the counterclockwise rotation of typical AFL. (+info)Hepatic vascular exclusion with preservation of the caval flow for liver resections. (4/230)
OBJECTIVE: To report the technique and results of an alternative method of vascular clamping during liver resections. BACKGROUND: Most liver resections require vascular clamping to avoid excessive blood loss. Portal triad clamping is often sufficient, but it does not suppress backflow bleeding, which can be prevented only by hepatic vascular exclusion. The latter method adds clamping of the inferior vena cava, which results in hypotension, requiring invasive anesthetic management. There is growing evidence that intermittent clamping is better tolerated than continuous clamping, especially in the presence of underlying liver disease. METHODS: Hepatic vascular exclusion with preservation of the caval flow (HVEPC) involved conventional inflow clamping associated with outflow control by clamping the major hepatic veins, thus avoiding caval occlusion. HVEPC was used in 40 patients undergoing major or complex liver resection, including 16 with underlying liver disease. HVEPC was total (clamping of the porta hepatis and all major hepatic veins) in 20 cases and partial (clamping of the porta hepatis and the hepatic veins of the resected territory) in 20. Clamping was continuous in 22 cases and intermittent in 18. Resections included 12 hemihepatectomies, 12 extended hepatectomies, 3 central hepatectomies, and 13 uni- or bisegmentectomies. RESULTS: Hemodynamic tolerance of clamping was excellent in all cases, without the need for therapeutic adjustment. Median red cell transfusion requirements were 0 units, and 28 patients (70%) did not receive any transfusions during the hospital stay. There were no deaths, and the morbidity rate was 17.5%. Median hospital stay was 10 days. CONCLUSION: HVEPC is a safe and effective procedure applicable to liver tumors without invasion to the inferior vena cava. It offers the advantages of conventional hepatic vascular exclusion without its hemodynamic drawbacks, and it can be applied intermittently or partially. (+info)Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. (5/230)
In elderly patients, aortic stiffness is a major determinant of increased end-systolic stress leading to left ventricular (LV) hypertrophy with impaired cardiac performance. However, in a rat model of aortic elastocalcinosis (induced by vitamin D(3)-nicotine [VDN] treatment), brief exposure (1 month) to increased aortic stiffness modified neither cardiac function nor cardiac structure. Here we report the impact of longer exposure (3 months) to aortic stiffness. Three months after induction of aortic stiffness, aortic characteristic impedance was measured in awake rats, 8 control and 10 VDN. Stroke volume was measured (electromagnetic probe) at baseline and after acute volume overload. LV weight/body weight ratio, collagen, and myosin heavy chain (MHC) contents were determined. Although aortic characteristic impedance increased (controls, 32+/-2; VDN rats, 50+/-8 10(3) dyne. s/cm(5); P=0.0248), stroke volume was maintained in VDN rats at baseline (controls, 223+/-18; VDN, 211+/-13 microL) and after volume overload (controls, 378+/-14; VDN, 338+/-15 microL). However, LV weight/body weight ratio (controls, 1.54+/-0.07; VDN, 1.73+/-0.05 g/kg; P=0.0397) and LV collagen content (controls, 31+/-4; VDN, 52+/-4 microgram/g dry wt; P=0.0192) increased. A shift from alpha-MHC (controls, 82+/-2%; VDN, 69+/-3%; P=0.0056) to beta-MHC (controls, 18+/-2%; VDN, 31+/-3%; P=0. 0056) was also observed. Three months' exposure to increased aortic stiffness in VDN rats induced LV hypertrophy with moderate interstitial fibrosis and a shift in the MHC-isoform pattern. Such structural adaptation maintains LV performance. (+info)Tissue factor activity is increased in human endothelial cells cultured under elevated static pressure. (6/230)
We tested the hypothesis that elevated blood pressure, a known stimulus for vascular remodeling and an independent risk factor for the development of atherosclerotic disease, can modulate basal and cytokine-induced tissue factor (TF; CD 142) expression in cultured human endothelial cells (EC). Using a chromogenic enzymatic assay, we measured basal and tumor necrosis factor-alpha (TNF-alpha; 10 ng/ml, 5 h)-induced TF activities in human aortic EC (HAEC) and vena cava EC (HVCEC) cultured at atmospheric pressure and at 170 mmHg imposed pressure for up to 48 h. Basal TF activities were 22 +/- 10 U/mg protein for HAEC and 14 +/- 9 U/mg protein for HVCEC and were upregulated in both cell types >10-fold by TNF-alpha. Exposure to pressure for 5 h induced additional elevation of basal TF activity by 47 +/- 16% (P < 0.05, n = 6) for HAEC and 17 +/- 5% (P < 0.05, n = 3) for HVCEC. Pressurization also enhanced TF activity in TNF-alpha-treated cells from 240 +/- 28 to 319 +/- 32 U/mg protein in HAEC (P < 0.05, n = 4) and from 148 +/- 25 to 179 +/- 0.8 U/mg protein (P < 0.05, n = 3) in HVCEC. Cytokine stimulation caused an approximately 100-fold increase in steady-state TF mRNA levels in HAEC, whereas pressurization did not alter either TF mRNA or cell surface antigen expression, as determined by quantitative RT-PCR methodology and ELISA. Elevated pressure, however, modulated the EC plasma membrane organization and/or permeability as inferred from the increased cellular uptake of the fluorescent amphipathic dye merocyanine 540 (33 +/- 7%, P < 0.05). Our data suggest that elevated static pressure modulates the hemostatic potential of vascular cells by modifying the molecular organization of the plasma membrane. (+info)Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. (7/230)
BACKGROUND: Saphenous vein grafts are widely used for aortocoronary bypass surgery as treatment for severe atherosclerosis and often are complicated by subsequent occlusion of the graft vessel. METHODS AND RESULTS: We described a mouse model of venous bypass graft arteriosclerosis that can be effectively retarded by locally applied suramin, a growth factor receptor antagonist. Mouse isogeneic vessels of the vena cava veins pretreated with suramin were grafted end to end into the carotid arteries and enveloped with a mixture of suramin (1 mmol/L) and pluronic-127 gel. In the untreated group, vessel wall thickening was observed as early as 1 week after surgery and progressed to 4-fold and 10-fold the original thickness in grafted veins at 4 and 8 weeks, respectively. Pluronic-127 gel alone did not influence neointima formation. Suramin treatment reduced the neointima hyperplasia 50% to 70% compared with untreated controls. Immunohistochemical studies demonstrated that a significant proliferation of vascular smooth muscle cells (SMCs) constituted neointimal lesions between 4 and 8 weeks. The majority of SMCs expressed platelet-derived growth factor (PDGF) receptors-alpha and -beta, which were significantly reduced by suramin treatment. In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity. CONCLUSIONS: Suramin inhibited SMC migration and proliferation in vivo and in vitro by blocking PDGF-initiated PDGF receptor and MAPK-AP-1 signaling. These findings indicate that locally applied suramin is effective in a mouse model of venous bypass graft arteriosclerosis. (+info)Aromatase and sex steroid receptors in human vena cava. (8/230)
Among sex steroids, especially estrogen metabolism has been considered to play a role in the function and pathology of human veins. We investigated the expression and activity of the estrogen-producing enzyme aromatase and estrogen receptor (ER) in human vena cava to assess possible in situ biosynthesis of estrogens and their modes of action. We first examined aromatase expression by immunohistochemistry in human inferior vena cava obtained from 29 autopsy cases (11 males, 18 females, 63.6 +/- 3.0 years old). We then semiquantitated the level of aromatase mRNA by reverse transcriptase-polymerase chain reaction in 24 cases and aromatase activity by 3H-water assay in 15 cases to examine whether or not and in which cell types aromatase was expressed. We also studied alternative use of multiple exon 1s of its gene and immunolocalization of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD I), which converts estrone produced by aromatase to estradiol, a biologically active estrogen and ER. Aromatase and 17beta-HSD I immunoreactivity were both detected in smooth muscle cells (SMC) of the media in all the cases and in endothelial cells (EC) in 20 and 22 cases, respectively. ER immunoreactivity was detected in SMC of vena cava in 21 cases. The amount of aromatase mRNA was significantly greater in the cases utilizing 1c (I.3) or 1d (P.II) of exon 1 (9 cases, 191.1 +/- 26.3 attomol/ng total RNA) than those utilizing 1b (I.4) as the promoter (14 cases, 50.6 +/- 13.0 attomol/ng total RNA) (p < 0.01). Significant correlation (p < 0.05) was observed between the amount of aromatase mRNA and aromatase activity in 15 cases examined. No significant correlation was detected between the amount of aromatase mRNA or aromatase labeling index and the ER status. These results suggest that estrone and estradiol are produced in the human vena cava and that their production is mediated by aromatase and 17beta-HSD I, respectively but not all of these locally synthesized estrogens may not work directly in situ. (+info)Superior Vena Cava Syndrome (SVCS) is a condition that occurs when the superior vena cava (SVC), the main vein that returns blood from the head, neck, and upper extremities to the heart, becomes blocked or narrowed. This blockage can be caused by a variety of factors, including cancer, blood clots, or other medical conditions. Symptoms of SVCS can include swelling in the face, neck, and arms, difficulty swallowing, shortness of breath, chest pain, and fatigue. In severe cases, SVCS can lead to serious complications, such as heart failure or stroke. Treatment for SVCS depends on the underlying cause of the blockage. In some cases, medications or minimally invasive procedures, such as angioplasty or stent placement, may be used to open the blocked vein. In more severe cases, surgery may be necessary to remove the blockage or bypass the affected area of the SVC.
Venae cavae
Vena caval foramen
Motion
Superior thyroid vein
Blood vessel
Anatomy of the human heart
Inferior vena cava
Vein
Superior vena cava
Low pressure receptors
Heart
Pericardial sinus
Congenital stenosis of vena cava
Cardiac physiology
Earl Wood
Central venous pressure
Neoclassical compound
Cavoatrial junction
Sinus venosus
Fontan procedure
Atrium (heart)
Diastole
Baroreflex
Biliary atresia
Andreas Vesalius
Hypoplastic right heart syndrome
Bainbridge reflex
Quinton catheter
Valve of inferior vena cava
Heart rate
Inferior Vena Cava Filters: Products, Design Features, Indications
The Cardiovascular System | Encyclopedia.com
Elmoselhi - Circuitry and Hemo Flashcards
Inferior Vena Cava Filters: Products, Design Features, Indications
2013 ICD-9-CM Diagnosis Code 747.41 : Total anomalous pulmonary venous connection
Alphabetical Browse | Britannica
NCLEX-PN Exam Cram: Caring for the Client with Disorders of the Cardiovascular System | Hypertension | InformIT
JCI -
Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns
Molecular basis of signaling specificity between GIRK channels and GPCRs | eLife
Inferior vena cava filter - wikidoc
Human Heart 4D Anatomy Model - Exploratorium
Portal Regional da BVS
Spinal cord protection during aortic cross-clamping using retrograde venous perfusion - Fingerprint - University of Arizona
Clayton K Trimmer - Research output - University of Texas Southwestern Medical Center
Routine use of the piggyback technique in pediatric orthotopic liver transplantation<...
In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary...
Cardiovascular regulation of supraoptic vasopressin neurons - HSC
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM - Terms starting with 'E' - MEDINDEX.AM
Patient Education Library | Cross River Cardiology
BVS Brasil
Biology of the Heart - Heart and Blood Vessel Disorders - MSD Manual Consumer Version
What Organs Make Up the Circulatory System? | Sciencing
Buy Xanax Uk Cheap - kitchentablecult.com
Pesquisa | Portal Regional da BVS
Page 1 | Search Results | Journal of Experimental Biology | The Company of Biologists
PDF) FILTER-BEARING IVC AND BILATERAL ILIOFEMORAL THROMBOSISrfs.sirweb.org/wp-content/uploads/Natour IVCFILTERthrombosis 01… ·...
Order Tramadol Next Day Shipping - trustingnews.org
199075883 case-pres-chf-with-hyperipidemia-and-uti | PPT
Inferior10
- In humans they are the superior vena cava and the inferior vena cava, and both empty into the right atrium. (wikipedia.org)
- The inferior vena cava (or caudal vena cava in some animals) travels up alongside the abdominal aorta with blood from the lower part of the body. (wikipedia.org)
- Inferior vena cava (IVC) filter placement is most commonly indicated for deep venous thrombosis (DVT) or pulmonary embolism (PE) when anticoagulation therapy is contraindicated. (medscape.com)
- If the infrarenal segment of the inferior vena cava is too short for a filter placement, the filter should be placed above the renal veins. (medscape.com)
- Anteroposterior image from an inferior venacavographic examination demonstrates an inferior vena cava of normal diameter without thrombus. (medscape.com)
- Inferior vena cava (IVC) filters are designed for their physical properties, clot-trapping effectiveness, ability to preserve flow in the IVC, and ease of placement. (medscape.com)
- The right side of the heart receives deoxygenated venous blood from the periphery by way of the superior and inferior venae cavae. (informit.com)
- An inferior vena cava filter is a medical device that is implanted into the inferior vena cava to prevent pulmonary emboli (PEs). (wikidoc.org)
- Your two largest veins are the superior and inferior vena cavae. (crossrivercardiology.com)
- The superior vena cava and inferior vena cava drain systemic venous blood into the posterior wall of the right atrium. (medscape.com)
Veins2
- The right atrium receives deoxygenated blood through coronary sinus and two large veins called venae cavae. (wikipedia.org)
- The superior vena cava (or cranial vena cava in animals) is above the heart, and forms from a convergence of the left and right brachiocephalic veins, which contain blood from the head and the arms. (wikipedia.org)
Coronary sinus1
- The internal wall of the right atrium is composed of a smooth posterior portion (into which the vena cavae and coronary sinus drain) and a ridgelike, muscular anterior portion. (medscape.com)
Pulmonary1
- The structures initially seen from this perspective include the superior vena cava, right atrium, right ventricle, pulmonary artery, and aorta. (medscape.com)
Superior8
- Superior vena cava syndrome, which occurs in approximately 15,000 persons in the United States annually, consists of a collection of symptoms and signs resulting from the obstruction of the superior vena cava (SVC). (escholarship.org)
- Herein, we report a case of superior vena cava syndrome diagnosed in our dermatology clinic. (escholarship.org)
- Proptosis, periorbital swelling, conjunctival suffusion and elevated intraocular pressure are common ophthalmic findings in superior vena cava syndrome [ 3 ]. (escholarship.org)
- Physical exam usually establishes the presence of superior vena cava syndrome. (escholarship.org)
- Additional known masses of the middle or right anterior mediastinum causing superior vena cava syndrome include enlarged paratracheal lymph nodes, lymphoma, leiomyosarcomas, carcinoids, germ cell tumors, fibrosing mediastinitis, intrathoracic goiter, thymoma, and aortic aneurysm. (escholarship.org)
- Iatrogenic thrombosis associated with central venous catheters is the most frequent cause of intraluminal occlusion of the superior vena cava. (escholarship.org)
- Timely diagnosis of superior vena cava syndrome and treatment of the underlying disease are critical, for increased cervical venous pressure can compromise the larynx and pharynx. (escholarship.org)
- In the outpatient setting, recognizing the early cutaneous presentation of superior vena cava syndrome requires a high index of suspicion. (escholarship.org)
Venous1
- A peristaltic wave appeared to travel along the lateral venae cavae to the branchial hearts, potentially aiding venous return. (biologists.com)
Renal2
- The presence of renal cell carcinoma within a solitary kidney and vena cava extension presents complex management and surgical decisions for the treating urologist. (elsevierpure.com)
- Tollefson, MK , Kawashima, A & Blute, ML 2005, ' In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary kidney ', Urology , vol. 66, no. 4, pp. 882.e1-882.e2. (elsevierpure.com)
Blood1
- Originally described in 1757 by William Hunter in a patient afflicted with a saccular aneurysm of the ascending aorta secondary to syphilis [ 2 ], this condition is characterized by compromised blood flow in the vena cava because of extrinsic compression or intraluminal occlusion. (escholarship.org)
Cava7
- The superior vena cava (or cranial vena cava in animals) is above the heart, and forms from a convergence of the left and right brachiocephalic veins, which contain blood from the head and the arms. (wikipedia.org)
- Although the Glenn operation, which involves the end-to-end anastomosis of the superior vena cava (SVC) to the right pulmonary artery, was described in 1958, it was primarily used as palliative surgery. (medscape.com)
- The superior vena cava ( SVC ) is a large valveless venous channel formed by the union of the brachiocephalic veins . (radiopaedia.org)
- The superior vena cava begins behind the lower border of the first right costal cartilage and descends vertically behind the first and second intercostal spaces to drain into the right atrium at the superior cavoatrial junction (at the level of the third costal cartilage). (radiopaedia.org)
- Comprehensive Imaging Review of the Superior Vena Cava. (radiopaedia.org)
- The structures initially seen from this perspective include the superior vena cava, right atrium, right ventricle, pulmonary artery, and aorta. (medscape.com)
- A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava. (ouhsc.edu)
Inferioris1
- Case of absence of pars praerenalis venae cavae inferioris in man, combined with deviations of vv. (nih.gov)